- NWL Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
S-3ASR Filing
Newell Brands (NWL) S-3ASRAutomatic shelf registration
Filed: 25 Mar 08, 12:00am
95-3571558 | ||
(Jurisdiction of incorporation if not a U.S. national bank) | (I.R.S. Employer Identification No.) | |
700 South Flower Street, Suite 500 Los Angeles, California (Address of principal executive offices) | 90017 (Zip code) |
Delaware | 36-3514169 | |
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) | |
10B Glenlake Parkway Suite 300 Atlanta, Georgia (Address of principal executive offices) | 30328 (Zip code) |
Item 1. | General Information. |
Item 2. | Affiliations with Obligor. |
Item 16. | List of Exhibits. |
1 | . | A copy of the articles of association of The Bank of New York Trust Company, N.A. (Exhibit 1 toForm T-1 filed with Registration StatementNo. 333-121948). | ||
2 | . | A copy of certificate of authority of the Trustee to commence business. (Exhibit 2 toForm T-1 filed with Registration StatementNo. 333-121948). | ||
3 | . | A copy of the authorization of the Trustee to exercise corporate trust powers. (Exhibit 3 toForm T-1 filed with Registration StatementNo. 333-121948). | ||
4 | . | A copy of the existing by-laws of the Trustee. (Exhibit 4 toForm T-1 filed with Registration StatementNo. 333-121948). | ||
6 | . | The consent of the Trustee required by Section 321(b) of the Act. | ||
7 | . | A copy of the latest report of condition of the Trustee published pursuant to law or to the requirements of its supervising or examining authority. |
By: | /s/ Janice Ott Rotunno |
Title: | Vice President |
By: | /s/ Janice Ott Rotunno |
Title: | Vice President |
Dollar amounts | ||||
in thousands | ||||
ASSETS | ||||
Cash and balances due from depository institutions: | ||||
Noninterest-bearing balances and currency and coin | 14,687 | |||
Interest-bearing balances | 0 | |||
Securities: | ||||
Held-to-maturity securities | 43 | |||
Available-for-sale securities | 216,332 | |||
Federal funds sold and securities purchased under agreements to resell: | ||||
Federal funds sold | 23,800 | |||
Securities purchased under agreements to resell | 89,400 | |||
Loans and lease financing receivables: | ||||
Loans and leases held for sale | 0 | |||
Loans and leases, net of unearned income | 0 | |||
LESS: Allowance for loan and lease losses | 0 | |||
Loans and leases, net of unearned income and allowance | 0 | |||
Trading assets | 0 | |||
Premises and fixed assets (including capitalized leases) | 12,676 | |||
Other real estate owned | 0 | |||
Investments in unconsolidated subsidiaries and associated companies | 0 | |||
Not applicable | ||||
Intangible assets: | ||||
Goodwill | 871,685 | |||
Other Intangible Assets | 300,982 | |||
Other assets | 152,943 | |||
Total assets | $ | 1,682,548 | ||
LIABILITIES | ||||
Deposits: | ||||
In domestic offices | 1,628 | |||
Noninterest-bearing | 1,628 | |||
Interest-bearing | 0 | |||
Not applicable | ||||
Federal funds purchased and securities sold under agreements to repurchase: | ||||
Federal funds purchased | 0 | |||
Securities sold under agreements to repurchase | 0 | |||
Trading liabilities | 0 | |||
Other borrowed money: | ||||
(includes mortgage indebtedness and obligations under capitalized leases) | 193,691 | |||
Not applicable | ||||
Not applicable | ||||
Subordinated notes and debentures | 0 | |||
Other liabilities | 161,803 | |||
Total liabilities | 357,122 | |||
Minority interest in consolidated subsidiaries | 0 | |||
EQUITY CAPITAL | ||||
Perpetual preferred stock and related surplus | 0 | |||
Common stock | 1,000 | |||
Surplus (exclude all surplus related to preferred stock) | 1,121,520 | |||
Retained earnings | 202,154 | |||
Accumulated other comprehensive income | 752 | |||
Other equity capital components | 0 | |||
Total equity capital | 1,325,426 | |||
Total liabilities, minority interest, and equity capital (sum of items 21, 22, and 28) | 1,682,548 | |||
Karen Bayz ) Vice President |
Michael K. Klugman, President | ) | |||||
Frank P. Sulzberger, MD | ) | Directors (Trustees | ) | |||
William D. Lindelhoff, Vice President | ) |